Clinical Trial Update: Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2b/3 trial update for NuSepin® in COVID-19 pneumonia is ongoing with unspecified status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• NuSepin®

Snippet

Sponsor: Shaperon | Conditions: COVID-19 Pneumonia | Phase 2, Phase 3 | Status: UNKNOWN